Rigel Pharmaceuticals Inc (RIGL)
Net Income Growth
229.08%
TTM · Period ending:
RIGL Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported229.08%period ending
Latest reported229.08%period ending
RIGL TTM Net Income YoY % (6.13% → 229.08%)
Year-over-year change
High-resolution chart · PNG
RIGL net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 229.0796% | |
| 879.6977% | |
| 1,999.0792% | |
| 2,819.3507% | |
| 787.3314% | |
| 287.7487% | |
| 169.6863% | |
| 115.8882% | |
| 62.3213% | |
| 55.6645% | |
| 57.1629% | |
| 70.4327% | |
| 55.3153% | |
| 47.3668% | |
| -226.9677% | |
| -469.366% | |
| -993.2488% | |
| -638.7394% | |
| 39.7727% | |
| 47.6306% | |
| 69.1004% | |
| 59.0525% | |
| 55.5356% | |
| 40.3715% | |
| 57.4019% | |
| 55.9559% | |
| 5.088% | |
| 53.3376% | |
| 37.1562% | |
| 26.8426% | |
| 9.6318% | |
| -47.0647% | |
| -28.609% | |
| -29.8169% | |
| -12.6791% | |
| -2.1082% | |
| -44.3324% | |
| -32.1888% | |
| -34.494% | |
| -8.6226% | |
| 33.143% | |
| 41.5482% | |
| 43.3889% | |
| 28.5952% | |
| 14.7773% | |
| -1.2151% | |
| -2.1128% | |
| 12.4347% | |
| 10.9711% | |
| 15.2944% | |
| 9.9282% | |
| 1.5299% | |
| -8.3379% | |
| -14.569% | |
| -14.9663% | |
| -28.0659% | |
| -911.257% | |
| -324.0404% | |
| -326.9016% | |
| -357.774% | |
| 80.7409% | |
| 137.9403% | |
| 133.9677% | |
| 125.068% | |
| 64.0465% | |
| 22.9975% | |
| 15.7156% | |
| -1.5544% | |
| -31.8641% | |
| -59.8593% | |
| -78.191% | |
| -66.8184% | |
| -57.1101% | |
| -82.605% | |
| -97.3377% | |
| -127.6051% | |
| -93.7665% | |
| -8.6652% | |
| 16.8353% | |
| 39.1767% | |
| 39.9878% | |
| 21.7168% | |
| 19.552% | |
| 4.3116% | |
| -12.4058% | |
| -17.0513% | |
| -36.5512% | |
| -42.7376% | |
| -32.4744% | |
| -27.4014% | |
| -11.253% | |
| -6.6551% | |
| -17.1119% | |
| -30.1281% | |
| -55.5556% | |
| -49.4864% | |
| -31.0226% | |
| -21.8713% | |
| 6.1317% |